Detalles de la búsqueda
1.
Thrombin Generation Assay in Antiphospholipid Antibodies Positive Subjects as a Personalized Thrombotic Risk Assessment: State of the Art and Perspectives.
Curr Rheumatol Rep
; 26(5): 178-187, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38372872
2.
Determination of four homogeneous subgroups of patients with antiphospholipid syndrome: a cluster analysis based on 509 cases.
Rheumatology (Oxford)
; 62(8): 2813-2819, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36190346
3.
A new pro-thrombotic mechanism of neutrophil extracellular traps in antiphospholipid syndrome: impact on activated protein C resistance.
Rheumatology (Oxford)
; 61(7): 2993-2998, 2022 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34791113
4.
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients.
Rheumatology (Oxford)
; 61(4): 1376-1384, 2022 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34363461
5.
Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Lupus
; 31(13): 1595-1605, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36112747
6.
Antiphospholipid syndrome in patients over 65 years: A comparative study of clinical and biological features and thrombotic relapses.
Lupus
; 31(14): 1816-1823, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36177950
7.
Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications.
Lupus
; 30(11): 1799-1807, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34284674
8.
Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?
Curr Rheumatol Rep
; 23(8): 65, 2021 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34218350
9.
Health-Related Quality of Life in Antiphospholipid Syndrome: Current Knowledge and Future Perspectives.
Curr Rheumatol Rep
; 22(6): 20, 2020 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32405870
10.
New Insights into the Use of Direct Oral Anticoagulants in Non-high Risk Thrombotic APS Patients: Literature Review and Subgroup Analysis from a Meta-analysis.
Curr Rheumatol Rep
; 22(7): 25, 2020 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32436109
11.
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature.
Curr Rheumatol Rep
; 18(12): 74, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27812956
12.
Direct Oral Anticoagulants in Antiphospholipid Syndrome: Too Early or Too Late?
Ann Intern Med
; 171(10): 765-766, 2019 11 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31610546
13.
Comment on: Failure of rivaroxaban to prevent thrombosis in four patients with anti-phospholipid syndrome: reply.
Rheumatology (Oxford)
; 57(5): 939-940, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29373692
14.
Circulating Endothelial Cells are Associated with Thromboembolic Events in Patients with Antiphospholipid Antibodies.
Thromb Haemost
; 123(1): 76-84, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35977699
15.
Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients.
J Thromb Haemost
; 21(5): 1258-1265, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36792010
16.
Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 Patients.
JAMA Dermatol
; 159(1): 62-67, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36477813
17.
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study.
RMD Open
; 9(2)2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37321669
18.
Failure of rivaroxaban to prevent thrombosis in four patients with anti-phospholipid syndrome.
Rheumatology (Oxford)
; 56(8): 1433-1434, 2017 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28431092
19.
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: Response to Comment.
Curr Rheumatol Rep
; 19(8): 52, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28741234
20.
Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Autoimmun Rev
; 21(10): 103158, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35907609